TABLE 3.
Treatment modality | Country | T1 n (%) | T2 n (%) | McNemar test | ||||
---|---|---|---|---|---|---|---|---|
Conclusion | Statistics | |||||||
df, n | χ 2 | p | q | |||||
Group 1a: Actively ill at both T1 and T2 (US n = 49; NL n = 89; SE n = 80) | ||||||||
Face‐to‐face | US | <5 (<5) | 12 (25) | – | – | |||
NL | 8 (9) | 35 (39) | T2 > T1 | 1, 89 | 23.3 | 1.4 × 10 −6 | 3.1 × 10 −6 | |
SE | 22 (28) | 23 (29) | NS | 1, 80 | 0 | 1 | 1 | |
Online | US | 31 (63) | 19 (40) | – | – | |||
NL | 50 (56) | 9 (10) | T1 > T2 | 1, 89 | 34 | 5.4 × 10 −9 | 3.0 × 10 −8 | |
SE | 8 (10) | 8 (10) | – | – | ||||
Not in treatment | US | 12 (24) | 15 (31) | – | – | |||
NL | 27 (30) | 37 (42) | NS | 1, 89 | 3.4 | .07 | .09 | |
SE | 46 (58) | 43 (54) | – | – |
Note: We displayed McNemar test statistics if tests were performed, and “–” in case the number of discordant pairs was <20. Differences between two time points are indicated by a bold font (q < .05). For these items, no responses were missing in US, no responses were missing in NL, and no responses were missing in SE.
Abbreviations: NL, Netherlands; NS, nonsignificant; SE, Sweden; US, United States.